Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank43
3Y CAGR-39.2%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-39.2%/yr
Annual compound
Percentile
P43
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 30.01% |
| 2024 | 91.72% |
| 2023 | 7.30% |
| 2022 | 133.43% |
| 2021 | 56.14% |
| 2020 | -72.06% |
| 2019 | 462.52% |
| 2018 | 0.00% |